Effectiveness of heparin versus NaCl 0,9% in central venous catheter flushing. A systematic review;Heparina frente a cloruro sódico 0,9% para mantener permeables los catéteres venosos centrales. Una revisión sistemática

Farmacia Hospitalaria

Volumn 29, Issue 4, 2005, Pages 258-264

  López Briz, Eduardo ^a   Ruiz Garcia V ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Central venous catheter; Flushing; Heparin; Infection; Patency; Systematic review; Thrombosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; HEPARIN; SODIUM CHLORIDE;

CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG EFFECT; DRUG EFFICACY; EMBASE; HUMAN; MEDLINE; METHODOLOGY; REVIEW; SYSTEMATIC REVIEW; THROMBOSIS;

EID: 27744438066     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-6343(05)73674-6     Document Type: Review

References (49)

1. McGee DC, Could MK. Preventing complications of central venous catheterization. N Engl J Med 2003; 34: 1123-33.
2. a ed. Philadelphia: Lippincott Williams and Wilkins, 2003. p. 281-96.
3. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132: 391-402.
4. Vaqué J, Roselló J, Grupo de Trabajo EPINE. Evolución de la prevalencia de las infecciones nosocomiales en los hospitales españoles. Proyecto EPINE 10 años (1990-1999). Sociedad Española de Medicina Preventiva, Salud Pública e Higiene, 2001.
5. Grupo de trabajo EPINE. Estudio de prevalencia de las infecciones nosocomiales 2003. Sociedad Española de Medicina Preventiva, Salud Pública e Higiene, 2003.
6. Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, non cuffed central venous catheters. Medicine 2002; 81: 466-79.
7. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003; 21: 3665-75.
8. O'Grady NP, Alexander M, Dellinger P, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2002; 35: 1281-307.
9. Cottee S. Heparin lock practice in total parenteral nutrition. Prof Nurse 1995; 11: 25-8.
10. Heeger PS, Backstrom JT. Heparin flushes and thrombocytopenia. Ann Intern Med 1986; 105: 143.
11. Rice L. Heparin-induced thrombocytopenia. Myths and misconceptions (that will cause trouble for you and your patient). Arch Intern Med 2004; 164: 1961-4.
12. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 1998; 113: 165-71.
13. Goode CJ, Titler M, Rakel B, Ones DS, Kleiber C, Small S, et al. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nurs Res 1991; 40: 324-30.
14. Infection control. Prevention of healthcare-associated infection in primary and community care. National Institute for Clinical Excellence. Disponible en http://www.nice.org.uk (consultado noviembre 2004).
15. Ariza J, León C, Rodríguez Noriega A, Fernández Mondejar E. Conferencia de consenso. Conclusiones de la conferencia de consenso en infecciones por catéter. Med Intensiva 2003; 27: 615-20.
16. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
17. Smith S, Dawson S, Hennessey R, Andrew M. Maintenance of the patency of indwelling central venous catheters: is heparin necessary? Am J Pediatr Hematol Oncol 1991; 13: 141-3.
18. Rabe C, Gramann T, Sons X, Berna M, González-Carmona MA, Klehr HU, et al. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Med 2002; 28: 1172-6.
19. American Association of Critical Care Nurses. Evaluation of the effects of heparinized and non heparinized flush solutions on the patency of arterial pressure monitoring lines: the AACN Thunder Project. Am J Crit Care 1993; 2: 3-15.
20. Abdelkefi A, Othman TB, Kammoun L, Chelli M, Romdhane NB, Kriaa A, et al. Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patientes with haemato-oncological disease. Thromb Haemost 2004; 92: 654-61.
21. Ankola PA, Atakent YS. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters. Am J Perinatol 1993; 10: 229-32.
22. Aquino VM, Sandler ES, Mustafa MM, Steele JW, Buchanan GR. A prospective double-blind randomized trial of urokinase flushes to prevent bacteremia resulting from luminal colonization of subcutaneous central venous catheters. J Pediatr Hematol Oncol 2002; 24: 710-3.
23. Branson PK, McCoy RA, Phillips BA, Clifton GD. Efficacy of 1.4 percent sodium citrate in maintaining arterial catheter patency in patients in a medical ICU. Chest 1993; 103: 882-5.
24. Buturovic J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P. Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artif Organs 1998; 22: 945-7.
25. Clifton GD, Branson P, Kelly HJ, Dotson LR, Record KE, Phillips BA, et al. Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency. Heart Lung 1991; 20: 115-8.
26. de Neef M, Heijboer H, van Woensel JB, de Haan RJ. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial. Pediatr Hematol Oncol 2002; 19: 553-60.
27. Dillon PW, Jones GR, Bagnall-Reeb HA, Buckley JD, Wiener ES, Haase GM. Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Study Group. J Clin Oncol 2004; 22: 2718-23.
28. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002; 13: 2133-9.
29. Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/ heparin flush solution: A randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18: 1269-78.
30. Hook ML, Reuling J, Luettgen ML, Norris SO, Elsesser CC, Leonard MK. Comparison of the patency of arterial lines maintained with heparinized and nonheparinized infusions. The Cardiovascular Intensive Care Unit Nursing Research Committee of St. Luke's Hospital. Heart Lung 1987; 16: 693-9.
31. Horgan MJ, Bartoletti A, Polansky S, Peters JC, Manning TJ, Lamont BM. Effect of heparin infusates in umbilical arterial catheters on frequency of thrombotic complications. J Pediatr 1987; 111: 774-8.
32. Kamala F, Boo NY, Cheah FC, Birinder K. Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates. Acta Paediatr 2002; 91: 1350-6.
33. Kulkarni M, Eisner C, Quellet D, Zeldin R. Heparinized saline versus normal saline in maintaining patency of the radial artery catheter. Can J Surg 1994; 37: 37-42.
34. rd, Summers BL, Pearson DC, Helsabeck CB. The effects of heparin flush on patency of the Groshong catheter: a pilot study. Oncol Nurs Forum 1996; 23: 1401-5.
35. Pouw L, Kilsby D, Francis P, Tulloh B. Heparin thromboprophylaxis via indwelling subcutaneous teflon cannula. Aust N Z J Surg 1995; 65: 793-5.
36. Rackoff WR, Weiman M, Jakobowski D, Hirschl R, Stallings V, Bilodeau J, et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 1995; 127: 147-51.
37. Ray CE Jr, Shenoy SS, McCarthy PL, Broderick KA, Kaufman JA. Weekly prophylactic urokinase instillation in tunneled central venous access devices. J Vasc Interv Radiol 1999; 10: 1330-4.
38. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990; 8: 1591-7.
39. Trivedi HS, Twardowski ZJ. Use of double-lumen dialysis catheters. Loading with locked heparin. ASAIO J 1997; 43: 900-3.
40. Smith I, Hathaway M, Goldman C, Ng J, Brunton J, Simor AE, et al. A randomized study to determine complications associated with duration of insertion of heparin locks. Res Nurs Health 1990; 13: 367-73.
41. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598-601.
42. Saint S. Prevention of intravascular catheter-associated infections. En: Shojania KG, Duncan BW, McDonald KM, Watcher RM (editores). Making Health care safer: a critical analysis of patient safety practices. Evidence report/Technology Assessment 43. Rockville: Agency for Healthcare Research and Quality, 2001.
43. Polderman KH, Girbes ARJ. Central venous catheter use. Part 2. Infectious complications. Intensive Care Med 2002; 28: 18-28.
44. Crnich C, Maki DG. The promise of novel technology for the prevention of intravascular device -related bloodstream infection. II. Long-term devices. Clin Infect Dis 2002; 34: 1362-8.
45. Trautner BW, Darouiche RO. Catheter-associated infections. Pathogenesis affects prevention. Arch Intern Med 2004; 164: 842-50.
46. Mermel LA. New technologies to prevent intravascular catheter-related bloodstream infections. Emerg Infect Dis 2001; 7: 197-9.
47. Sociedad Española de Medicina Preventiva, Salud Pública e Higiene. Prevención y control de las bacteriemias asociadas al uso de catéteres venosos centrales (CVCs). Disponible en: http://www.mpsp.org/ mpsp/Documentos/inf_nosoc/cateter (acceso enero 2005).
48. Weber DR. Is heparin really necessary in the lock and, if so, how much? DICP Ann Pharmacother 1991; 25: 399-407.
49. El sellado incorrecto de catéteres fue la causa del contagio de hepatitis C en el Hospital de Alcorcón. Disponible en http://www. comtf.es/NOTICIAS/NOTICIAS%202004_8.html#anchor23240 (acceso agosto de 2004).